Molecular and Cellular Biochemistry

, Volume 272, Issue 1–2, pp 179–185 | Cite as

Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-α-lipoic acid

  • Elangovan Selvakumar
  • Chidambaram Prahalathan
  • Yenjerla Mythili
  • Palaninathan VaralakshmiEmail author


The present study investigated the protective effect of DL-α-lipoic acid on the tissue peroxidative damage and abnormal antioxidant levels in cyclophosphamide (CP) induced hepatotoxicity. Male Wistar rats of 140± 20 g were categorized into four groups. Two groups were administered CP (15 mg/kg body weight once a week for 10 weeks by oral gavage) to induce hepatotoxicity; one of these groups received lipoic acid treatment (35 mg/kg body weight intraperitoneally once a week for 10 weeks; 24 h prior to the CP administration). A vehicle (saline) treated control group and a lipoic acid drug control group were also included. The extent of liver damage in CP-induced rats was evident from the increased activities of serum aminotransferases, alkaline phosphatase and lactate dehydrogenase; whereas lipoic acid pretreatment prevented the rise in these marker enzymes. We evaluated the changes in activities/levels of tissue enzymic (superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase and glucose-6-phosphate dehydrogenase) and non-enzymic (reduced glutathione, ascorbate and α-tocopherol) antioxidants along with malondialdehyde levels in the experimental groups. In CP-administered rats the antioxidant enzymes showed significantly depressed activities (p < 0.001, p < 0.01) and the antioxidant molecules also showed depleted levels (p < 0.001, p < 0.01), in comparison with the control group. However the extent of lipid peroxidation and the abnormal antioxidant status were normalized in lipoic acid pretreated rats. The present work highlights the efficacy of lipoic acid as a cytoprotectant in CP-induced hepatic oxidative injury.


antioxidants cyclophosphamide hepatotoxicity lipid peroxidation lipoic acid oxidative stress 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dollery C: Therapeutic Drugs. Churchill Livingstone, Edinburgh, 1999, pp C349–C354Google Scholar
  2. 2.
    Fraiser LH, Kanekal S, Kehrer JP: Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42: 781–795, 1991PubMedGoogle Scholar
  3. 3.
    Capel ID, Jenner M, Dorrell HM, Williams DC: Hepatic function assessed (in rats) during chemotherapy with some anti-cancer drugs. Clin Chem 25: 1381–1383, 1979PubMedGoogle Scholar
  4. 4.
    Honjo I, Suou T, Hirayama C: Hepatotoxicity of cyclophosphamide in man: Pharmacokinetic analysis. Res Commun Chem Pathol Pharmacol 61: 149–165, 1988PubMedGoogle Scholar
  5. 5.
    Bhattacharya A, Lawrence RA, Krishnan A, Zaman K, Sun D, Fernandes G: Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice. J Am Coll Nutr 22: 388–399, 2003PubMedGoogle Scholar
  6. 6.
    Stankiewicz A, Skrzydlewska E, Makiela M: Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol Drug Interact 19: 67–82, 2002PubMedGoogle Scholar
  7. 7.
    Bergendi L, Benes L, Durackova Z, Ferencik M: Chemistry, physiology and pathology of free radicals. Life Sci 65: 1865–1874, 1999CrossRefPubMedGoogle Scholar
  8. 8.
    Manda K, Bhatia AL: Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19: 367–372, 2003CrossRefPubMedGoogle Scholar
  9. 9.
    Navarova J, Ujhazy E, Dubovicky M: Protective effect of the antioxidant stobadine against cyclophosphamide and irradiation induced oxidative stress. Gen Physiol Biophys 18 Spec No: 112–119, 1999Google Scholar
  10. 10.
    Packer L, Witt EH, Tritschler HJ: Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227–250, 1995CrossRefPubMedGoogle Scholar
  11. 11.
    Biewenga GP, Haenen GR, Bast A: The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29: 315–331, 1997PubMedGoogle Scholar
  12. 12.
    King J: The dehydrogenases or oxidoreductases–lactacte dehydrogenase. In: D. Van (ed). Practical Clinical Enzymology. Nostrand Company Limited, London, pp 83–93, 1965Google Scholar
  13. 13.
    King J: The transferases – alanine and aspartate transaminase. In: D. Van (ed). Practical Clinical Enzymology. Nostrand Company Limited, London, 1965, pp 121–138Google Scholar
  14. 14.
    King J: The phosphohydrolases- acid and alkaline phosphatases. In: D. Van (ed). Practical Clinical Enzymology. Nostrand Company Limited, London, 1965, pp 191–208Google Scholar
  15. 15.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951PubMedGoogle Scholar
  16. 16.
    Hogberg J, Larson RE, Kristoferson A, Orrenius S: NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem Biophys Res Commun 56: 836–842, 1974CrossRefPubMedGoogle Scholar
  17. 17.
    Devasagayam TPA: Lipid peroxidation in rat uterus. Biochim Biophys Acta 876: 507–514, 1986PubMedGoogle Scholar
  18. 18.
    Sinha AK: Colorimetric assay of catalase. Anal Biochem 47: 389–394, 1972PubMedGoogle Scholar
  19. 19.
    Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469–474, 1974PubMedGoogle Scholar
  20. 20.
    Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: Biochemical role as a component of glutathione peroxidase. Science 179: 588–590, 1973PubMedGoogle Scholar
  21. 21.
    Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139, 1974PubMedGoogle Scholar
  22. 22.
    Staal GE, Visser J, Veeger C: Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 185: 39–48, 1969PubMedGoogle Scholar
  23. 23.
    Beutler E: Active transport of glutathione disulfide from erythrocytes. In: A. Larson, S. Orrenius, A. Holmgren, B. Mannerwik (eds). Functions of glutathione—Biochemical, physiological, toxicological and clinical aspects. Raven Press, New York, 1983, p 65Google Scholar
  24. 24.
    Moron MS, Depierre JW, Mannervik B: Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67–78, 1979PubMedGoogle Scholar
  25. 25.
    Omaye ST, Turnbull JD, Sauberlich HE: Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62: 3–11, 1979PubMedGoogle Scholar
  26. 26.
    Desai ID: Vitamin E analysis methods for animal tissues. Methods Enzymol 105: 138–147, 1984PubMedGoogle Scholar
  27. 27.
    Sulkowska M, Sulkowski S, Skrzydlewska E: The effect of pentoxifylline on ultrastructure and antioxidant potential during cyclophosphamide-induced liver injury. J Submicrosc Cytol Pathol 3: 413–422, 1999Google Scholar
  28. 28.
    Mathew S, Kuttan G: Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res 16: 407–411, 1997PubMedGoogle Scholar
  29. 29.
    Ghosh S, Ghosh D, Chattopadhyay S, Debnath J: Effect of ascorbic acid supplementation on liver and kidney toxicity in cyclophosphamide-treated female albino rats. J Toxicol Sci 24: 141–144, 1999Google Scholar
  30. 30.
    Al-Nasser IA: In vivo prevention of cyclophosphamide-induced Ca2+ dependent damage of rat heart and liver mitochondria by cyclosporin A. Comp Biochem Physiol A Mol Integr Physiol 12: 209–214, 1998Google Scholar
  31. 31.
    Plaa GL, Hewitt WR: Detection and evolution of chemically induced liver injury. In: A.W. Hayes (ed). Principles and methods of toxicology. Raven press, New York, 1986, pp 401–441Google Scholar
  32. 32.
    Berrigan MJ, Struck RF, Gurtoo HL: Lipid peroxidation induced by cyclophosphamide. Cancer Biochem Biophys ([0-9]+): 265–270, 1987PubMedGoogle Scholar
  33. 33.
    Fridovich I: Superoxide dismutases. Annu Rev Biochem 44: 147–159, 1975PubMedGoogle Scholar
  34. 34.
    Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, Remacle J: Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 51: 283–297, 1990PubMedGoogle Scholar
  35. 35.
    Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C: Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab Dispos 19: 625–629, 1991PubMedGoogle Scholar
  36. 36.
    Dirven HA, van Ommen B, van Bladeren PJ: Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res 54: 6215–6220, 1994PubMedGoogle Scholar
  37. 37.
    Yoshida A, Haung IY: Structure of human glucose-6-phosphate dehydrogenase. In: A. Yoshida, E. Beutler (ed). Glucose-6-phosphate dehydrogenase. Academic press, New York, 1986, pp 473– 482Google Scholar
  38. 38.
    Gutierrez-Correa J, Stoppani AO: Inactivation of yeast glutathione reductase by Fenton systems: Effect of metal chelators, catecholamines and thiol compounds. Free Radic Res 27: 543–555, 1997PubMedGoogle Scholar
  39. 39.
    Lee IM: Antioxidant vitamins in the prevention of cancer. Proc Assoc Am Physicians 111: 10–15, 1999PubMedGoogle Scholar
  40. 40.
    Bhanumathi P, Devi PU: Modulation of glutathione depletion and lipid peroxidation by WR-77913 an 2-mercaptopropionylglycine in cyclophosphamide chemotherapy. Indian J Exp Biol 32: 562–564, 1994PubMedGoogle Scholar
  41. 41.
    Packer L, Tritschler HJ, Wessel K: Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Rad Biol Med 22: 359–378, 1997PubMedGoogle Scholar
  42. 42.
    Moini H, Packer L, Saris NE: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182: 84–90, 2002PubMedGoogle Scholar
  43. 43.
    Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L: Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6: 321–338, 1997PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Elangovan Selvakumar
    • 1
  • Chidambaram Prahalathan
    • 1
  • Yenjerla Mythili
    • 1
  • Palaninathan Varalakshmi
    • 1
    • 2
    Email author
  1. 1.Department of Medical Biochemistry, Dr. A.L.M. Post Graduate Institute of Basic Medical SciencesUniversity of MadrasChennaiIndia
  2. 2.Department of Medical Biochemistry, Dr. A.L.M. Post Graduate Institute of Basic Medical SciencesUniversity of MadrasChennaiIndia

Personalised recommendations